Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immune cell therapies and immune cell engineering

Original research

Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies

Online download statistics by month:

Online download statistics by month: January 2022 to March 2024

	Abstract	Full	Pdf
Jan 2022	229	235	70
Feb 2022	412	445	154
Mar 2022	157	164	55
Apr 2022	167	176	68
May 2022	85	85	43
Jun 2022	128	130	42
Jul 2022	117	118	33
Aug 2022	100	102	47
Sep 2022	99	104	47
Oct 2022	103	105	29
Nov 2022	56	56	43
Dec 2022	55	55	12
Jan 2023	63	63	16
Feb 2023	69	72	19
Mar 2023	37	38	27
Apr 2023	20	20	8
May 2023	30	31	18
Jun 2023	34	34	23
Jul 2023	35	35	22
Aug 2023	52	53	41
Sep 2023	63	65	22
Oct 2023	43	43	26
Nov 2023	47	50	29
Dec 2023	53	55	22
Jan 2024	27	27	18
Feb 2024	38	38	22
Mar 2024	45	46	26
Total	2364	2445	982